25 of the Best Pediatric Hematologist Oncologists Near Me in lanham, MD

AeRang Kim, MD, PhD, is a member of the solid tumor faculty at Children’s National Hospital and an Associate Professor of Pediatrics. Dr. Kim's specializes in sarcomas and developmental therapeutics. Her research focuses on development of novel therapeutics for pediatric cancer including pre-clinical testing of novel agents, pharmacokinetic analysis, developing innovative methods for toxicity monitoring and clinical trial design. She serves as the principal investigator of multiple early phase trials in pediatric oncology, sarcomas and NF1 associated tumors. Dr. Kim is highly rated in 8 conditions, according to our data. Her clinical expertise encompasses Malignant Peripheral Nerve Sheath Tumor, Neurofibromatosis Type 1 (NF1), Neurofibromatosis, and Adult Soft Tissue Sarcoma. Dr. Kim is board certified in Pediatrics: American Board Of Pediatrics, 2004 and Pediatric Hematology-Oncology: American Board Of Pediatrics, 2009.

Holly Meany, MD, is a pediatric oncologist and director of the Solid Tumor Program at Children’s National Hospital. She also serves as an associate professor of pediatrics at George Washington University. Dr. Meany is dedicated to finding better treatments for children with cancer through research and clinical care. Her work focuses on developing new therapies for pediatric solid tumors. She designs and leads early-phase clinical trials to test promising treatments and understand how they work in children. Dr. Meany has played a key role in several national studies, including large trials for neuroblastoma, a type of childhood cancer. She recently led an international study for children with newly diagnosed non-high-risk neuroblastoma and is currently helping to develop the next high-risk neuroblastoma trial, both through the Children’s Oncology Group. Dr. Meany is also exploring innovative approaches like immunotherapy—using the body’s own immune system to fight cancer. She has led international studies using specialized T cells to treat patients with relapsed solid tumors and is now working on combining these novel T cells with CAR T-cell therapy for children with relapsed cancers. In addition to her research, Dr. Meany is passionate about training the next generation of pediatric cancer specialists. As director of the Pediatric Hematology-Oncology Fellowship Program at Children’s National, she mentors and supports future leaders in the field. Dr. Meany is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Neuroblastoma, Hereditary Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Osteosarcoma, and Mastoidectomy. Dr. Meany is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 2006 and Pediatrics: American Board Of Pediatrics, 2003.

Luca Szalontay is a Pediatric Hematologist Oncology provider practicing medicine in Washington, Washington, D.c.. Dr. Szalontay is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Glioma, Diffuse Midline Glioma H3 K27M-Mutant, Medulloblastoma, and Brain Stem Cancer. Dr. Szalontay is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 2021 and Pediatrics: American Board Of Pediatrics, 2015. Dr. Szalontay is currently accepting new patients.

Lea Mayer is a Pediatric Hematologist Oncology provider practicing medicine in Washington, Washington, D.c.. Dr. Mayer is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Neuroblastoma, Hereditary Neuroblastoma, Ewing Sarcoma, and Osteosarcoma. Dr. Mayer is board certified in Oncology Nursing Certification Corporation, 2015 and Primary Care Certified Pediatric Nurse Practitioner (CPNP-PC): Pediatric Nursing Certification Board, 2010.

Urania Dagalakis, MD, MHSc, specializes in pediatric oncology and hematology. She completed her clinical training at Johns Hopkins University and conducted her research work within the National Cancer Institute of the National Institutes of Health. Due to her research background she specializes in caring for children with rare tumors and hereditary cancer syndromes. Dr. Dagalakis is the director of the Cancer Genetics Clinic at Children’s National Hospital. She is also an assistant professor of pediatrics at The George Washington University School of Medicine and Health Sciences and a physician in the Center for Cancer and Blood Disorders. She is committed to empowering families with knowledge, supporting survivorship and leading innovations in personalized cancer care. Her work bridges compassionate patient care with clinical research focused on improving outcomes for children with genetic cancer predispositions. Dr. Dagalakis is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Hemoglobin SC Disease and Immune Thrombocytopenic Purpura (ITP). Dr. Dagalakis is board certified in Pediatrics: American Board Of Pediatrics, 2023.

Shelby Smith is a Pediatric Hematologist Oncology specialist and a Pediatrics provider practicing medicine in Washington, Washington, D.c.. Dr. Smith is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL). Dr. Smith is board certified in Pediatric Nursing Certification Board, 2016.

Hyojeong Han is a Pediatric Hematologist Oncology specialist and a Transfusion Medicine provider practicing medicine in Washington, Washington, D.c.. Dr. Han is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Hemoglobinopathy, Anemia, and Hemolytic Anemia. Dr. Han is board certified in American Board Of Pathology, 2021, American Board Of Pediatrics, 2021, and American Board Of Pediatrics, 2016. Dr. Han is currently accepting new patients.

Ashley Lanzel, MD, MA, trained in pediatrics at Johns Hopkins Hospital, pediatric hematology-oncology at Emory/Children’s Healthcare of Atlanta, and hospice and palliative medicine at the National Institutes of Health. While at Emory University, she obtained a Master of Arts in bioethics. Her research focus is in decision-making, communication, palliative oncology and pediatric palliative ethics. She enjoys being a clinical educator. When she is not at work, she is having fun with her kids. Her clinical expertise encompasses GM1 Gangliosidosis. Dr. Lanzel is board certified in American Board Of Pediatrics, 2022, Pediatrics: American Board Of Pediatrics, 2015, and Pediatric Hematology-Oncology: American Board Of Pediatrics, 2019.

Hannah Kinoshita, MD, is an oncologist in the Division of Oncology in the Center for Cancer and Blood Disorders. Her research interests include cellular immunotherapy for high-risk hematologic malignancies. Her clinical expertise encompasses Multisystem Inflammatory Syndrome in Children (MIS-C), Acute Lymphoblastic Leukemia (ALL), Leukemia, Medulloblastoma, and Bone Marrow Transplant. Dr. Kinoshita is board certified in American Board Of Pediatrics, 2018 and Pediatric Hematology-Oncology: American Board Of Pediatrics, 2023.

Jennifer Levine is a Pediatric Hematologist Oncology provider practicing medicine in Washington, Washington, D.c.. Her clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Malignant Peripheral Nerve Sheath Tumor, Febrile Neutropenia, and Medulloblastoma. Dr. Levine is board certified in American Board Of Pediatrics, 2003 and American Board Of Pediatrics, 2006.

Hari Sankaran is a Pediatric Hematologist Oncology provider practicing medicine in Washington, Washington, D.c.. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Malignant Peripheral Nerve Sheath Tumor, Neurofibromatosis Type 1 (NF1), and Neurofibromatosis. Dr. Sankaran is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 2017 and Pediatrics: American Board Of Pediatrics, 2012.

Susan Whiteway is a Pediatric Hematologist Oncology provider practicing medicine in Washington, Washington, D.c.. Her clinical expertise encompasses Chromosome 7p Deletion, Ewing Sarcoma, RASopathies, and Osteosarcoma. Dr. Whiteway is board certified in Pediatrics: American Board Of Pediatrics, 2009 and Pediatric Hematology-Oncology: American Board Of Pediatrics, 2013.

Denise Casey is a Pediatric Hematologist Oncology provider practicing medicine in Washington, Washington, D.c.. Dr. Casey is board certified in Pediatrics: American Board Of Pediatrics, 2005 and American Board Of Pediatrics, 2011.

Michael Terao, MD, MEd, is a bone marrow transplant hospitalist at Children’s National Hospital and also works as the assistant dean for student learning at the Georgetown University School of Medicine. He received his Bachelor of Arts in English at Allegheny College in Meadville, PA. Dr. Terao graduated from Eastern Virginia Medical School and completed a pediatric residency at UCSF Benioff Children’s Hospital Oakland. After completing residency, he served as pediatric chief resident at the Morehouse School of Medicine Pediatric Residency. He then completed pediatric hematology/oncology fellowship at St. Jude Children's Research Hospital. Dr. Terao also received his Master of Education in the health professions from the Johns Hopkins University. As a cancer survivor himself, Dr. Terao strongly believes in the importance of delivering clinical care that is of the highest quality possible while also being compassionate and empathetic. Dr. Terao has published multiple peer-reviewed manuscripts with his research interests focusing on how to best support learners in medical education who struggle with multiple choice question examinations. Dr. Terao is board certified in general pediatrics and pediatric hematology/oncology. Dr. Terao is board certified in Pediatrics: American Board Of Pediatrics, 2016 and Pediatric Hematology-Oncology: American Board Of Pediatrics, 2021.

Brianna Nolan is a Pediatric Hematologist Oncology provider practicing medicine in Washington, Washington, D.c.. Dr. Nolan is board certified in Pediatric Nursing Certification Board, 2024. Dr. Nolan is currently accepting new patients.

Katie McHugh, CPNP-AC, is a pediatric nurse practitioner with the Leukemia and Lymphoma and Histiocytosis Programs within the Children’s National Cancer and Blood Disorders Center. She received her undergraduate degree from the University of North Carolina in 2007, holds a master’s degree from the University of Maryland, and earned her nurse practitioner degree from the University of Virginia. She has worked in pediatric oncology for over a decade and a half. She is an active board member of the Washington, D.C., chapter of the Association of Pediatric Hematology/Oncology Nurses. Outside of work, she enjoys running, gardening and cheering on the Tar Heels during basketball season. Dr. Mchugh is board certified in Acute Care Certified Pediatric Nurse Practitioner (CPNP-AC): Pediatric Nursing Certification Board, 2023.